U.S. Life Sciences Stock News

NYSE:NX
NYSE:NXBuilding

A Look At Quanex Building Products (NX) Valuation After New Governance And Tyman Mexico Investigation

Why the new investigation matters for Quanex Building Products (NX) shareholders An investigation into Quanex Building Products (NX) has been launched after allegations that management did not fully disclose underinvestment and equipment issues at its Tyman Mexico facility, raising fresh questions about governance and integration execution. See our latest analysis for Quanex Building Products. Quanex Building Products’ recent 30 day share price return of 22.11% and 90 day share price return...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Protagonist Therapeutics Milestones Test Valuation As NDAs And Trials Advance

Protagonist Therapeutics submitted NDAs for Icotrokinra in plaque psoriasis and Rusfertide in polycythemia vera, advancing two late stage drug candidates. The company is progressing Phase 3 trials in partnership with large pharmaceutical companies, including Johnson & Johnson and Takeda. These filings and trial advances represent fresh milestones for NasdaqGM:PTGX that have not yet been widely discussed in the market. Protagonist Therapeutics, trading on NasdaqGM:PTGX, is drawing fresh...